Health ❯Healthcare ❯Medical Research

Oncology

Glioblastoma Breast Cancer Prostate Cancer Colorectal Cancer Head and Neck Cancer Acute Myeloid Leukemia Melanoma Pediatric Oncology Bladder Cancer Clinical Trials

Nankai Team Finds 15-Genus Tumor Microbiome Signature That Predicts GI Cancer Outcomes

Authors call for prospective validation prior to any clinical application.

NF1-Low ER+ Breast Cancers Identified as Likely Responders to CDK4/6 Inhibitors

Blood Microbial DNA Classifier Accurately Distinguishes Primary Liver Cancer From Colorectal Metastases

Harmonized Classification Reveals Survival Gains and Persistent Gaps in European Childhood Brain Tumors

Celcuity’s Gedatolisib Combos Yield Up to 76% Progression-Free Survival Gain in Phase 3 Trial

Dana-Farber Study Calls for Fusion-Specific Testing in NUT Carcinoma Diagnosis

Inhibiting Pyroptosis with Belnacasan Resensitizes Bladder Tumors to Chemotherapy

FDA Clears MT-125 for First Human Trials in Treatment-Resistant Glioblastoma

Uncommitted Neuroblastoma Cells Linked to Tumor Regression

Genomic Test Predicts Chemotherapy Resistance in Cancer Patients

UCSF Researchers Target Variant Bladder Cancer With CAR-T Therapy

Dual Enzyme Inhibitors Convert Neuroblastoma Tumors into Healthy Neurons in Mice

Low-Dose Vitamin D Supplementation Enhances Chemotherapy Success in Breast Cancer Trial

EGFR Inhibitors Show Promise Against Immunotherapy-Resistant NF1-Mutant Melanoma

Phase 3 Trial Launches to Test Electric Field and Immunotherapy Combo in Glioblastoma

ASCO Conference Showcases Lifestyle-Adapted Immunotherapy and Promising Cancer Vaccines

PROX1 gene drives aggressive, treatment-resistant prostate cancer

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

Triplet Therapy Doubles Survival in BRAF V600E Metastatic Colorectal Cancer

Comprehensive NGS Study Unveils Diverse Mutational Landscape in Lung Squamous Cell Carcinoma